Saturday, 7 November 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 24, 2026

OceanaGold Q4 Earnings Call Highlights

View original at finance.yahoo.com
OceanaGold Q4 Earnings Call Highlights OceanaGold logo Key Points OceanaGold delivered a record 2025 with expanded margins and cash generation — including adjusted EBITDA up 49%, record free cash flow of $259 million, and a strongest-ever balance sheet with zero debt and $477 million in cash…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The board approved a tripling of the quarterly dividend and a doubling of the share buyback for 2026, resulting in up to $432 million of total shareholder returns—an increase of 112% year-over-year

    80% confidence
  • The growth in 2026 production is driven primarily by Haile, where guidance reflects a 35% increase in output

    80% confidence
  • Front-end engineering is commencing now and development would take about two years, starting sometime next year, with first development ore toward the back end of 2029 and sustainable ore production from 2030 onward

    80% confidence
  • The company's M&A strategy has not changed and inorganic opportunities remain an option, though not a priority focus

    80% confidence
  • Haile's unit costs are expected to decline 25% year-over-year

    80% confidence
  • Horseshoe Underground decline advance is a full year ahead of mine sequence

    80% confidence
  • An updated technical report is scheduled for release at the end of March and will outline mining the next phase of Ledbetter from underground, which improves margins and overall net present value

    80% confidence
  • Didipio met production guidance and in Q4 produced approximately 24,000 ounces of gold and 3,200 tons of copper

    80% confidence
  • All four sites increased production in Q4 and each met its production guidance for the year

    80% confidence
  • Record free cash flow of $259 million exceeded the company's total free cash flow generated in all of 2024

    80% confidence
  • The first half of 2026 will focus on resource-to-reserve conversion at Wharekirauponga, with a plan for more than 30 drill holes targeting 300,000 ounces of reserves

    80% confidence
  • Total growth and exploration capital is planned to rise to $340 million in 2026, about 2.5 times 2025 levels

    80% confidence
  • The company ended the period in its strongest net cash position to date, with zero debt and cash of $477 million, up 42% from the prior quarter

    80% confidence
  • 2026 guidance implies higher production and lower AISC, alongside increased spending on value-accretive capital projects

    80% confidence
  • Full-year AISC at Didipio came in around the top end of the guided range

    80% confidence
  • The cash increase came despite more than $100 million returned to shareholders in Q4 through dividends and buybacks

    80% confidence
  • Q4 was the strongest quarter of the year at Waihi at just under 22,000 ounces

    80% confidence
  • The company recorded record average realized gold price of just over $4,200 per ounce in Q4

    80% confidence
  • The mine plan is expected to produce above 200,000 ounces per year from 2026 through 2031

    80% confidence
  • Results were achieved at an average realized gold price of around $3,500 an ounce, which was below current spot levels at the time of the call

    80% confidence
  • An updated technical report for Didipio is expected in the first half of the year to detail remaining work to reach sustained mining rates and to provide an updated life-of-mine plan

    80% confidence
  • OceanaGold set annual records for EBITDA, EBITDA margins, net profit, earnings per share, operating cash flow, and free cash flow

    80% confidence
  • Adjusted EPS included roughly a $0.26 per share impact from share-based compensation in Q4

    80% confidence
  • An illustrative slide assumes a $4,700 gold price and implies about a 40% payout ratio using guidance midpoints and a reasonable gold price assumption

    80% confidence
  • The company signed earn-in agreements in 2025 with Headwater Gold in Nevada and Carolina Rush in South Carolina

    80% confidence
  • Q4 represented the strongest production quarter of the year, with increased production from all four operating sites

    80% confidence
  • Investments in mine resilience, including underground pumping infrastructure, helped keep operations running through extreme weather events at Didipio

    80% confidence
  • Updated technical report for Macraes expected at the end of March is slated to show a five-year mine life extension to 2032 using a $2,200 gold price assumption

    80% confidence
  • In the second half, the team will follow up what appears to be a new higher-grade zone to the south with eight drill holes targeting growth of 150,000 ounces of inferred resources

    80% confidence
  • Macraes produced 56,000 ounces in Q4, aided by access to higher-grade open-pit ore following waste stripping at Innes Mills earlier in 2025

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com